Malaysia, Singapore Join Hands On Review Of Generic Drugs
Executive Summary
The National Pharmaceutical Regulatory Agency and the Health Sciences Authority have announced a pilot to kick-off their new initiative on the simultaneous assessment of new generic drugs.
You may also be interested in...
International Regulators Explain Work-Sharing Scheme For Biosimilars
New guidance from the ACCESS Consortium of regulators from five countries explains how biosimilar drug sponsors can apply for an internationally-coordinated review of new products.
EMA, HTA Bodies & Payers Explore Common Ground On Use Of RWE
A technical workshop is planned for later this year to identify common “use cases” for real-world evidence that are important to the European Medicines Agency, health technology assessment bodies and payers.
Misinformation Prompted Six Court Cases Against EU COVID-19 Vaccine Approvals In 2021
The EU’s conditional approval of four COVID-19 vaccines and its decision to extend the use of Pfizer/BioNTech’s Comirnaty to a younger age group were challenged in the court last year but the cases were declared inadmissible.